4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-17-009086
Options or other derivatives
- CEO and Director acquired 185,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MENDLEIN JOHN CEO and Director | 2017-02-07 | Grant or award · Employee Stock Option (right to buy) | +185,000 | 185,000 | D | ||
Loading xslF345X03/doc4.xml…